Dr. David Chu, M.D.

Dr. David Chu, M.D. is currently a member of Aldeyra’s Cornea Scientific Advisory Board. He is an international key opinion leader in areas of uveitis, ocular immunology and cornea surgeries. He is currently acting as a principal investigator in numerous research projects and clinical trials. In 2006, Dr. Chu was the first to report the outbreak of Fusarium Keratitis associated with use of Renu with Moisture Loc contact lens solution in America to the Federal Health Authority. After the FDA & CDC investigation, he was credited for identifying the link between Bausch & Lomb contact lens solution and the sight threatening fungal cornea infection which was featured in the NY Times.

He lectures and teaches nationally and abroad along with providing cutting edge patient care. He is the first surgeon to perform DMEK and DSEK procedures, the least invasive forms of cornea transplantation, in the New York and New Jersey metro area. Dr. Chu also serves as Team Physician for the NY Jets.